University Of Tasmania
145388 - asperuloside enhnaces taste perception.pdf (2.42 MB)
Download file

Asperuloside enhances taste perception and prevents weight gain in high-fat fed mice

Download (2.42 MB)
journal contribution
posted on 2023-05-21, 00:52 authored by Ishaq, M, Duyen TranDuyen Tran, Wu, Y, Nowak, K, Bianca DeansBianca Deans, Xin, JTZ, Loh, HL, Ng, WY, Yee, CW, Southam, B, Vicenzi, S, Cameron RandallCameron Randall, Yang, C, Emma Tan, Pasupuleti, M, Grewal, AK, Tauseef AhmadTauseef Ahmad, Madhur ShastriMadhur Shastri, Vicario, C, Ronci, M, Zuccarini, M, Martin BleaselMartin Bleasel, Paul ScowenPaul Scowen, Raffaeli, W, Da Andrea, G, Chellappan, DK, Glenn JacobsonGlenn Jacobson, Alexander BissemberAlexander Bissember, Jason SmithJason Smith, Rajaraman Eri, Canales, J, Miguel IglesiasMiguel Iglesias, Nuri GuvenNuri Guven, Vanni CarusoVanni Caruso
Asperuloside is an iridoid glycoside found in many medicinal plants that has produced promising anti-obesity results in animal models. In previous studies, three months of asperuloside administration reduced food intake, body weight, and adipose masses in rats consuming a high fat diet (HFD). However, the mechanisms by which asperuloside exerts its anti-obesity properties were not clarified. Here, we investigated homeostatic and nutrient-sensing mechanisms regulating food intake in mice consuming HFD. We confirmed the anti-obesity properties of asperuloside and, importantly, we identified some mechanisms that could be responsible for its therapeutic effect. Asperuloside reduced body weight and food intake in mice consuming HFD by 10.5 and 12.8% respectively, with no effect on mice eating a standard chow diet. Fasting glucose and plasma insulin were also significantly reduced. Mechanistically, asperuloside significantly reduced hypothalamic mRNA ghrelin, leptin, and pro-opiomelanocortin in mice consuming HFD. The expression of fat lingual receptors (CD36, FFAR1-4), CB1R and sweet lingual receptors (TAS1R2-3) was increased almost 2-fold by the administration of asperuloside. Our findings suggest that asperuloside might exert its therapeutic effects by altering nutrient-sensing receptors in the oral cavity as well as hypothalamic receptors involved in food intake when mice are exposed to obesogenic diets. This signaling pathway is known to influence the subtle hypothalamic equilibrium between energy homeostasis and reward-induced overeating responses. The present pre-clinical study demonstrated that targeting the gustatory system through asperuloside administration could represent a promising and effective new anti-obesity strategy.


Publication title

Frontiers in Endocrinology








School of Pharmacy and Pharmacology


Frontiers Research Foundation

Place of publication


Rights statement

Copyright © 2021 Ishaq, Tran, Wu, Nowak, Deans, Xin, Loh, Ng, Yee, Southam, Vicenzi, Randall, Yang, Tan, Pasupuleti, Grewal, Ahmad, Shastri, Vicario, Ronci, Zuccarini, Bleasel, Scowen, Raffaeli, D’Andrea, Chellappan, Jacobson, Bissember, Smith, Eri, Canales, Iglesias, Guven and Caruso. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License (

Repository Status

  • Open

Socio-economic Objectives

Treatment of human diseases and conditions